Most growth strategies, when examined honestly, reduce to one move: see more patients. Add a clinician. Fill the schedule tighter. Reduce gaps between sessions. The lever is volume.
The ceiling on volume is well-documented. Research on clinician burnout converges consistently on the same finding: workload is the most significant driver of clinician burnout, and burnout is the most significant driver of attrition. Replacing a clinician costs 90–200% of annual salary. The volume strategy, pursued past a threshold, eats its own margin.
The strategy is to raise revenue per patient without raising caseload. There is a current viable mechanisms.
Remote Therapeutic Monitoring
RTM (CPT 98975–98981) is the most concrete current example. The structured between-session review of patient-reported data, mood, sleep, CBT homework adherence, symptom severity, is reimbursable under Medicare Part B in 2026.
In many cases clinicians are already doing the work. A thoughtful clinician already reviews their patient's between-session experience before the next session. RTM formalizes this, attaches the data to the chart, and creates a billable revenue line for review work that was previously uncompensated. The patient receives more structured between-session attention. The clinician receives credit for what they were already doing. The practice gains revenue without raising caseload.
Where this lands for the practice
A practice that adds $80–$150 per active patient per month in additional reimbursable revenue (the realistic conservative range for RTM under Medicare Part B and where commercial coverage exists) does not need to add another clinician to grow. It's growing per-patient. The growth lever is mathematically distinct from caseload pressure. The clinician burnout curve is unaffected.
The honest version of the argument
The practices taking this seriously are positioning for the next decade. The ones still betting on volume alone are running a strategy the workforce data already shows isn't working.